{
    "2020-02-09": [
        [
            {
                "time": "2020-01-01",
                "original_text": "“下注中国”十大核心资产之十：迈瑞医疗（300760.SZ）",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "核心资产",
                        "医疗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-01-02",
                "original_text": "医药私募一哥，谈疫情下的医药股",
                "features": {
                    "keywords": [
                        "医药私募",
                        "疫情",
                        "医药股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-01-03",
                "original_text": "低估值的海翔药业为什么难受投资者青睐？",
                "features": {
                    "keywords": [
                        "海翔药业",
                        "低估值",
                        "投资者"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-01-04",
                "original_text": "我们不是基建狂魔，我们只是为了救人拼尽全力争分夺秒",
                "features": {
                    "keywords": [
                        "基建",
                        "救人",
                        "努力"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "基建",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-01-05",
                "original_text": "好消息！湖北新增病例创近6日新低，抗新冠肺方获批，中美创新药差距大，头部公司市值差距近4倍",
                "features": {
                    "keywords": [
                        "湖北",
                        "新增病例",
                        "新冠",
                        "药方获批",
                        "中美差距",
                        "市值差距"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}